Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 14 results
Author
Title
Type
Year
Filters:
Author
is
Tomlins, Scott A
[Clear All Filters]
2016
Fontugne J
,
Davis K
,
Palanisamy N
,
Udager A
,
Mehra R
,
McDaniel AS
,
Siddiqui J
,
Rubin MA
,
Mosquera JMiguel
,
Tomlins SA
. 2016.
Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry.
.
Mod Pathol. 29(2):157-65.
Beltran H
,
Prandi D
,
Mosquera JMiguel
,
Benelli M
,
Puca L
,
Cyrta J
,
Marotz C
,
Giannopoulou E
,
Chakravarthi BVSK
,
Varambally S
et al.
. 2016.
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.
.
Nat Med. 22(3):298-305.
Evans JR
,
Zhao SG
,
S Chang L
,
Tomlins SA
,
Erho N
,
Sboner A
,
Schiewer MJ
,
Spratt DE
,
Kothari V
,
Klein EA
et al.
. 2016.
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
.
JAMA Oncol. :1-10.
2015
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative clinical genomics of advanced prostate cancer.
.
Cell. 161(5):1215-28.
2010
Park K
,
Tomlins SA
,
Mudaliar KM
,
Chiu Y-L
,
Esgueva R
,
Mehra R
,
Suleman K
,
Varambally S
,
Brenner JC
,
MacDonald T
et al.
. 2010.
Antibody-based detection of ERG rearrangement-positive prostate cancer.
.
Neoplasia. 12(7):590-8.
2009
Tomlins SA
,
Bjartell A
,
Chinnaiyan AM
,
Jenster G
,
Nam RK
,
Rubin MA
,
Schalken JA
. 2009.
ETS gene fusions in prostate cancer: from discovery to daily clinical practice.
.
Eur Urol. 56(2):275-86.
Mosquera J-M
,
Mehra R
,
Regan MM
,
Perner S
,
Genega EM
,
Bueti G
,
Shah RB
,
Gaston S
,
Tomlins SA
,
Wei JT
et al.
. 2009.
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
.
Clin Cancer Res. 15(14):4706-11.
2006
Perner S
,
Demichelis F
,
Beroukhim R
,
Schmidt FH
,
Mosquera J-M
,
Setlur S
,
Tchinda J
,
Tomlins SA
,
Hofer MD
,
Pienta KG
et al.
. 2006.
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
.
Cancer Res. 66(17):8337-41.
2005
Varambally S
,
Yu J
,
Laxman B
,
Rhodes DR
,
Mehra R
,
Tomlins SA
,
Shah RB
,
Chandran U
,
Monzon FA
,
Becich MJ
et al.
. 2005.
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.
.
Cancer Cell. 8(5):393-406.
Dhanasekaran SMohan
,
Dash A
,
Yu J
,
Maine IP
,
Laxman B
,
Tomlins SA
,
Creighton CJ
,
Menon A
,
Rubin MA
,
Chinnaiyan AM
. 2005.
Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty.
.
FASEB J. 19(2):243-5.
Tomlins SA
,
Rhodes DR
,
Perner S
,
Dhanasekaran SM
,
Mehra R
,
Sun X-W
,
Varambally S
,
Cao X
,
Tchinda J
,
Kuefer R
et al.
. 2005.
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
.
Science. 310(5748):644-8.
2004
Kumar-Sinha C
,
Shah RB
,
Laxman B
,
Tomlins SA
,
Harwood J
,
Schmitz W
,
Conzelmann E
,
Sanda MG
,
Wei JT
,
Rubin MA
et al.
. 2004.
Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer.
.
Am J Pathol. 164(3):787-93.
Hofer MD
,
Fecko A
,
Shen R
,
Setlur SR
,
Pienta KG
,
Tomlins SA
,
Chinnaiyan AM
,
Rubin MA
. 2004.
Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.
.
Neoplasia. 6(5):503-12.
Rubin MA
,
Varambally S
,
Beroukhim R
,
Tomlins SA
,
Rhodes DR
,
Paris PL
,
Hofer MD
,
Storz-Schweizer M
,
Kuefer R
,
Fletcher JA
et al.
. 2004.
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer.
.
Cancer Res. 64(11):3814-22.